您要查找的是不是：
- Objective To investigate the changes of renal function during carboplatin (CBDCA) combined chemotherapy in patients with ovarian carcinoma. 目的观察应用卡铂联合化疗过程中患者肾功能的变化。
- Carboplatin, a drug derived from cisplatin, is approved by FDA. FDA批准顺铂的衍生物-卡铂.
- Chemotherapy was:ADR 10 mg, 5-Fu 1000 mg, Carboplatin 40mg. 化疗方案如下:阿霉素10mg、5-Fu1000mg、卡铂40mg。
- OBJECTIVE：To study the stability of carboplatin suppository. 目的：对新研制的卡铂栓进行稳定性实验研究。
- Carboplatin, a drug deried from cisplatin, is approed by FDA. FDA批准顺铂的衍生物-卡铂.
- It can not improve the inhibition ratio of tumor cell by carboplatin +MPA. 卡铂与甲孕酮联用时对A549细胞没有明显的提高生长抑制率;不具有统计学意义;P>0.;05。
- Gemcitabine plus carboplatin was associated with "moderate aderse reactions. 二氟脱氧胞嘧啶核苷联合卡铂给药伴随有“适度的副作用。”
- Methods 26 courses of postoperative systemic CBDCA therapy were carried out in 7 patients with ovarian carcinoma. 方法选择术后接受卡铂联合化疗方案的卵巢癌患者7例，共观察26个疗程。
- We used POC (PYM,VCR,CBDCA) scheme to treat 48 cases of spuamous cell cancer,of which 30 were of esophageal squamous cell cancer and 18 of lung squamous cell cancer. 用POC方案（PYM，VCR，CBDCA）治疗鳞状细胞癌48例，其中食管鳞状细胞癌30例，肺鳞癌18例。
- Carboplatin is one of the most important anticancer drugs among the second generation of platinum metal-based drugs, and widely used in clinics. 摘要卡铂是第二代铂类金属抗癌药物最重要的药物之一，广泛应用于临床。
- Methods Thirteen patients with invasive bladder cancer underwent partial cystectomy and received IIAC once during operation with high-does CBDCA and ADM. 方法13例浸润性膀胱癌患者均行膀胱部分切除术,术中同时行髂内动脉穿刺,单次大剂量灌注卡铂和阿霉素,行区域性化疗。
- The experimental study on in vivo pharmacokinetics of carboplatin liposomes via intralymphatic vessel perfusion. 经淋巴管灌注卡铂脂质体的药代动力学实验研究。
- The vi ncristine, etoposide, and carboplatin (VEC) were used in the chemoreduction trea tment. 化学减容术采用长春新碱， 卡铂和依托箔苷（VEC）方案。
- Objective To observe the efficacy and side effects of carboplatin solution in comparison with carboplatin powder. 目的观察国产卡铂注射液的疗效及毒性，并与卡铂粉针剂比较。
- Using molecular modification to reduce the side effect, cis-platin was modified to carboplatin. 透过改造分子结构去减少副作用，顺铂被改造变成卡铂。
- The vincristine, etoposide, and carboplatin (VEC) were used in the chemoreduction treatment. 化学减容术采用VEC方案即依托泊苷、长春新碱和卡铂。
- Cisplatin or carboplatin should have creatinine clearance measured at baseline and then every 3-5 years as needed. 顺铂或卡铂的药物治疗应该有最低限度的肌酸酐清除率，根据需要每3到5年检查一次。
- In North America, this would usually be carboplatin and in Europe it would be cisplatin. 在北美常用卡铂，在欧洲则是顺铂。
- Smith LE et al Carboplatin（Parap lin；JM8）and etoposied as fitst line Combination therapy for small cell lung Cancer. 黄德平，唐永平等，晚期肺癌支气管动脉内灌注化疗并放疗的疗效中华肿瘤杂志1990；
- Conclusions The results indicated that carboplatin combined chemotherapy could induce disturbances of renal function. 结论应用卡铂联合化疗，可引起肾功能障碍。
